In this case study-driven presentation, hear how one founder turned a platform concept into a credible partner for big pharma—before a single asset was in the clinic. From leading multi-million dollar AI-based discovery deals at Absci to building a new venture at Lily Gateway Labs, this talk offers practical insights into what it takes to successfully market, scale, and exit a platform company in today’s competitive environment.
- Learn how to position an early-stage platform to secure partnerships with big pharma—even without clinical assets.
- Hear lessons from high-profile partnerships with Merck, EQRx, AZ, and Almirall, including what worked (and what didn’t).
- Explore how platform companies can build credibility, define value, and navigate partnership dynamics from startup to acquisition.
